USFDA completes audit at Dr. Reddy’s Laboratories’ Hyderabad plant

12 Jul 2019 Evaluate

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ API Manufacturing Plant 2 at Bollaram, Hyderabad. The audit was completed on July 12, 2019. The company has been issued a Form 483 with 5 observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1215.70 7.25 (0.60%)
30-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1215.70
Cipla 1323.95
Zydus Lifesciences 888.50
Lupin 2150.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×